Tag: biogen
-
FDA approves Biogen drug for lead genetic cause of infant death
The U.S. Food and Drug Administration on Friday said it has approved Biogen Inc’s drug to treat spinal muscular atrophy, the leading genetic cause of death in infants. It is the first FDA-approved medicine for spinal muscular atrophy, a devastating disease that affects about one in 10,000 live births. The drug, nusinersen, which was discovered…
-
U.S. drugmaker Biogen’s profit beats Street; CEO to leave
(Reuters) – Biogen Inc's quarterly adjusted profit blew past Wall Street estimates on higher sales of its multiple sclerosis drugs, and the company said Chief Executive George Scangos would leave in the coming months. Shares of the company, whose board also authorized a $5 billion share repurchase program, rose about 5 percent to $276 in…